Preevacuation serum CA 125 in complete hydatidiform mole

Gynecologic Oncology

Volumn 64, Issue 3, 1997, Pages 487-489

  Tangtrakul, Somsak ^a   Srisupandit, Somkeart ^a   Chailurkit, La Or ^a   Rajatanavin, Rajata ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; TUMOR ANTIGEN;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; DRUG BLOOD LEVEL; FEMALE; FIRST TRIMESTER PREGNANCY; HISTOLOGY; HUMAN; HYDATIDIFORM MOLE; IMMUNORADIOMETRIC ASSAY; PRIORITY JOURNAL; TISSUE SECTION; TROPHOBLASTIC DISEASE;

EID: 0031106279     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.4584     Document Type: Article

References (13)

1. 1. Bast RC, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC: Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 68:1331-1337, 1981
2. 2. Welander CE: What do CA 125 and other antigens tell us about ovarian cancer biology? Acta Obstet Gynecol Scand 71(Suppl 155):85-93, 1992
3. 3. Niloff JM, Knapp RC, Schaetzl E, Reynolds C, Bast RC: CA 125 Antigen levels in obstetrics and gynecologic patients. Obstet Gynecol 64:703-707, 1984
4. 4. Halila H, Stenman U, Seppala M: Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy. Cancer 57:1327-1329, 1986
5. 5. Barbieri RL, Niloff JM, Bast RC, Schaetzl E, Kistner RW, Knapp RC: Elevated serum concentrations of CA 125 in patients with advanced endometriosis. Fertil Steril 45:630-634, 1986
6. 6. Seki K, Kikuchi Y, Uesato T, Kato K: Increased serum CA 125 levels during the first trimester of pregnancy. Acta Obstet Gynecol Scand 65:583-585, 1986
7. 7. Kobayashi F, Takashima E, Sagawa N, Mori T, Fujii S: Maternal serum CA 125 levels in early intrauterine and tubal pregnancies. Arch Gynecol Obstet 252:185-189, 1993
8. 8. Koonings PP, Schlaerth JB: CA 125: A marker for persistent gestational trophoblastic disease? Gynecol Oncol 49:240-242, 1993
9. 9. Morrow CP, Townsend DE: Tumors of the Placental Trophoblast, in Synopsis Gynecologic Oncology. New York, Wiley Medical, 1987, 3rd ed, p 367
10. 10. Soto-Wright V, Bernstein M, Goldstein DP, Berkowitz RS: The changing clinical presentation of complete molar pregnancy. Obstet Gynecol 86:775-779, 1995
11. 11. Jacobs IJ, Fay TN, Stabile I, Bridges JE, Oram DH, Grudzinskas JG: The distribution of CA 125 in the reproductive tract of pregnant and non-pregnant women. Br J Obstet Gynecol 95:1190-1194, 1988
12. 12. Fleuren GJ, Nap M, Aalders JG, Trimbos JB, Bruijn HWA: Explanation of the limited correlation between tumor CA 125 content and serum CA 125 antigen levels in patients with ovarian tumors. Cancer 60:2437-2442, 1987
13. 13. Fuith LC: The distribution of CA 125 in the reproductive tract of pregnant and non-pregnant women. Br J Obstet Gynecol 96:750, 1989 (letter; comment)